These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7826898)

  • 41. Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.
    Dearden CE; Else M; Catovsky D
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():21-4. PubMed ID: 21599603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.
    Dearden CE; Matutes E; Hilditch BL; Swansbury GJ; Catovsky D
    Br J Haematol; 1999 Aug; 106(2):515-9. PubMed ID: 10460614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances in the treatment of hairy-cell leukaemia.
    Mey U; Strehl J; Gorschlüter M; Ziske C; Glasmacher A; Pralle H; Schmidt-Wolf I
    Lancet Oncol; 2003 Feb; 4(2):86-94. PubMed ID: 12573350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hairy cell leukaemia: review of treatment.
    Kurzrock R; Talpaz M; Gutterman JU
    Br J Haematol; 1991 Oct; 79 Suppl 1():17-20. PubMed ID: 1718389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.
    Dutcher JP; Salva KM; Wiernik PH
    Am J Clin Oncol; 1990 Aug; 13(4):290-3. PubMed ID: 2198792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hairy cell leukemia: new understanding of biology and treatment.
    Saven A; Piro LD; Carrera CJ; Carson DA; Beutler E
    Cancer Treat Res; 1993; 64():15-34. PubMed ID: 7680875
    [No Abstract]   [Full Text] [Related]  

  • 48. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
    Else M; Dearden CE; Matutes E; Forconi F; Lauria F; Ahmad H; Kelly S; Liyanage A; Ratnayake V; Shankari J; Whalley I; Catovsky D
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():75-8. PubMed ID: 21504288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is it really possible to cure hairy cell leukemia patients only with frontline therapy?
    Zinzani PL; Stefoni V; Broccoli A; Pellegrini C; Gandolfi L; Casadei B; Maglie R; Pileri S; Argnani L
    Ann Hematol; 2014 Sep; 93(9):1565-9. PubMed ID: 24752417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fifty years of hairy cell leukemia treatments.
    Golomb HM
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():3-5. PubMed ID: 21599600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of hairy-cell leukemia.
    Lill MC; Golde DW
    Blood Rev; 1990 Dec; 4(4):238-44. PubMed ID: 1706207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Jehn U; Bartl R; Dietzfelbinger H; Vehling-Kaiser U; Wolf-Hornung B; Hill W; Heinemann V
    Ann Hematol; 1999 Mar; 78(3):139-44. PubMed ID: 10211756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Successful ambulatory treatment of patients with hairy-cell leukemia using one cycle of the purine analog cladribine. 'Hemato-oncologic volwassen Nederland' (HOVON) Study Group].
    Raemaekers JM; van 't Veer MB; Bogman MJ
    Ned Tijdschr Geneeskd; 1996 Aug; 140(31):1600-4. PubMed ID: 8768814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient.
    Pollio F; Pocali B; Palmieri S; Morabito P; Scalia G; Del Vecchio L; Ferrara F
    Ann Hematol; 2002 Dec; 81(12):736-8. PubMed ID: 12483372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hairy-cell leukemia (a review of the literature and the authors' own data)].
    Volkova MA; Lepkov SV; Frenkel' MA; Lebedeva NB; Tupitsyn NN
    Ter Arkh; 1994; 66(7):43-9. PubMed ID: 7985128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The disease with hope: hairy cell leukemia.
    Becker SE
    Clin J Oncol Nurs; 2007 Oct; 11(5):731-5. PubMed ID: 17962181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of pentostatin and alpha interferon in splenectomized patients with active hairy cell leukemia: an intergroup study. Cancer and Leukemia Group B and South-West Oncology Group.
    Rai KR
    Leuk Lymphoma; 1994; 14 Suppl 1():107-8. PubMed ID: 7820040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
    Lichtman SM; Wasil T; Ahmad M; Brody J
    Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [50-year-old man with weight loss and splenomegaly].
    Austein T; Schmitt A
    Dtsch Med Wochenschr; 2009 Feb; 134(6):251-2. PubMed ID: 19180417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.